Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Wang Website

Xin Wei Wang, Ph.D.

Selected Publications

1)  Roessler S, Budhu A, Wang XW.
Deciphering cancer heterogeneity: the biological space.
Frontiers in Cell and Developmental Biology. 2: 12, 2014.
Full Text Article. [Journal]
2)  Yamashita T, Kitao A, Matsui O, Hayashi T, Nio K, Kondo M, Ohno N, Miyati T, Okada H, Yamashita T, Mizukoshi E, Honda M, Nakanuma Y, Takamura H, Ohta T, Nakamoto Y, Yamamoto M, Takayama T, Arii S, Wang XW, Kaneko S.
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.
Hepatology. 2014.
3)  Dang HT, Budhu A, Wang XW.
The origin of cancer stem cells.
J. Hepatol. 2014.
4)  Hsiao TH, Chen HI, Roessler S, Wang XW, Chen Y.
Identification of genomic functional hotspots with copy number alteration in liver cancer.
EURASIP J Bioinform Syst Biol. 2013: 14, 2013.
5)  Ozdemir B, Abd-Almageed W, Roessler S, Wang XW.
iSubgraph: Integrative Genomics for Subgroup Discovery in Hepatocellular Carcinoma Using Graph Mining and Mixture Models.
PLoS ONE. 8: e78624, 2013.
6)  Yamashita T, Wang XW.
Cancer stem cells in the development of liver cancer.
J. Clin. Invest. 123: 1911-8, 2013.
7)  Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, Karoly E, Qin L, Ye Q, Jia H, Fan J, Sun H, Tang Z, Wang XW.
Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated with Progression of Hepatocellular Carcinoma and Patient Outcomes.
Gastroenterology. 144: 1066-1075, 2013.
8)  Ji J, Yu L, Yu Z, Forgues M, Uenishi T, Kubo S, Wakasa K, Zhou J, Fan J, Tang ZY, Fu S, Zhu H, Jin JG, Sun HC, Wang XW.
Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma.
Int. J. Biol. Sci. 9: 303-12, 2013.
9)  Oikawa T, Kamiya A, Zeniya M, Chikada H, Hyuck AD, Yamazaki Y, Wauthier E, Tajiri H, Miller LD, Wang XW, Reid LM, Nakauchi H.
SALL4, a stem cell biomarker in liver cancers.
Hepatology. 57: 1469-83, 2013.
10)  Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, Hara Y, Zeng SS, Hayashi T, Kondo M, Takatori H, Yamashita T, Mizukoshi E, Ikeda H, Zen Y, Takamura H, Wang XW, Kaneko S.
Discrete nature of EpCAM(+) and CD90(+) cancer stem cells in human hepatocellular carcinoma.
Hepatology. 57: 1484-97, 2013.
Click Here to View Expanded Bibliography.

This page was last updated on 4/5/2014.